North America Anthrax Vaccines Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Info Research
117 Pages
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.


Scope of the Report:
This report focuses on the Anthrax Vaccines in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biog`nesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Sant` Animale
Intervac
JOVAC

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
Live Vaccines
Cell free PA Vaccines

Market Segment by Applications, can be divided into
Human Use
Animal Use

There are 15 Chapters to deeply display the North America Anthrax Vaccines market.

Chapter 1, to describe Anthrax Vaccines Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Anthrax Vaccines, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Anthrax Vaccines, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Anthrax Vaccines market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Anthrax Vaccines Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents
1 Market Overview
1.1 Anthrax Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Live Vaccines
1.2.2 Cell free PA Vaccines
1.3 Market Analysis by Applications
1.3.1 Human Use
1.3.2 Animal Use
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Emergent BioSolutions
2.1.1 Profile
2.1.2 Anthrax Vaccines Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Emergent BioSolutions News
2.2 Merial
2.2.1 Profile
2.2.2 Anthrax Vaccines Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merial Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Merial News
2.3 Merck
2.3.1 Profile
2.3.2 Anthrax Vaccines Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Merck Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Merck News
2.4 Zoetis
2.4.1 Profile
2.4.2 Anthrax Vaccines Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Zoetis News
2.5 Bayer Sanidad Animal
2.5.1 Profile
2.5.2 Anthrax Vaccines Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Bayer Sanidad Animal News
2.6 Colorado Serum
2.6.1 Profile
2.6.2 Anthrax Vaccines Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Colorado Serum News
2.7 PharmAthene
2.7.1 Profile
2.7.2 Anthrax Vaccines Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 PharmAthene News
2.8 Tiankang
2.8.1 Profile
2.8.2 Anthrax Vaccines Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Tiankang News
2.9 Biog?nesis-Bago
2.9.1 Profile
2.9.2 Anthrax Vaccines Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Biog?nesis-Bago Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Biog?nesis-Bago News
2.10 CAVAC
2.10.1 Profile
2.10.2 Anthrax Vaccines Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 CAVAC News
2.11 Rosenbusch
2.11.1 Profile
2.11.2 Anthrax Vaccines Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Rosenbusch News
2.12 Agrovet
2.12.1 Profile
2.12.2 Anthrax Vaccines Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Agrovet News
2.13 Vecol
2.13.1 Profile
2.13.2 Anthrax Vaccines Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Vecol News
2.14 CVCRI
2.14.1 Profile
2.14.2 Anthrax Vaccines Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 CVCRI News
2.15 IVPM
2.15.1 Profile
2.15.2 Anthrax Vaccines Type and Applications
2.15.2.1 Type 1
.2.2 Type 2
2.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15.4 Business Overview
2.15.5 IVPM News
2.16 Prondil
2.16.1 Profile
2.16.2 Anthrax Vaccines Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16.4 Business Overview
2.16.5 Prondil News
2.17 CDV
2.17.1 Profile
2.17.2 Anthrax Vaccines Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 CDV Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17.4 Business Overview
2.17.5 CDV News
2.18 Indian Immunologicals
2.18.1 Profile
2.18.2 Anthrax Vaccines Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18.4 Business Overview
2.18.5 Indian Immunologicals News
2.19 Botswana Vaccine Institute
2.19.1 Profile
2.19.2 Anthrax Vaccines Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19.4 Business Overview
2.19.5 Botswana Vaccine Institute News
2.20 Ceva Sant? Animale
2.20.1 Profile
2.20.2 Anthrax Vaccines Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Ceva Sant? Animale Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20.4 Business Overview
2.20.5 Ceva Sant? Animale News
2.21 Intervac
2.21.1 Profile
2.21.2 Anthrax Vaccines Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21.4 Business Overview
2.21.5 Intervac News
2.22 JOVAC
2.22.1 Profile
2.22.2 Anthrax Vaccines Type and Applications
2.22.2.1 Type 1
2.22.2.2 Type 2
2.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22.4 Business Overview
2.22.5 JOVAC News
3 North America Anthrax Vaccines Market Competition, by Manufacturer
3.1 North America Anthrax Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Anthrax Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Anthrax Vaccines Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Anthrax Vaccines Manufacturer Market Share
3.4.2 Top 5 Anthrax Vaccines Manufacturer Market Share
3.5 Market Competition Trend
4 North America Anthrax Vaccines Market Analysis by Countries
4.1 North America Anthrax Vaccines Sales Market Share by Countries
4.2 North America Anthrax Vaccines Sales by Countries (2012-2017)
4.3 North America Anthrax Vaccines Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Anthrax Vaccines by Type
5.1 North America Anthrax Vaccines Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Anthrax Vaccines Sales and Market Share by Type (2012-2017)
5.1.2 North America Anthrax Vaccines Revenue and Market Share by Type (2012-2017)
5.2 Live Vaccines Sales Growth and Price
5.2.1 North America Live Vaccines Sales Growth (2012-2017)
5.2.2 North America Live Vaccines Price (2012-2017)
5.3 Cell free PA Vaccines Sales Growth and Price
5.3.1 North America Cell free PA Vaccines Sales Growth (2012-2017)
5.3.2 North America Cell free PA Vaccines Price (2012-2017)
6 North America Market Segmentation Anthrax Vaccines by Application
6.1 North America Anthrax Vaccines Sales Market Share by Application (2012-2017)
6.2 Human Use Sales Growth (2012-2017)
6.3 Animal Use Sales Growth (2012-2017)
7 United States Anthrax Vaccines Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Anthrax Vaccines Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Anthrax Vaccines Sales and Market Share by Type
7.3 United States Anthrax Vaccines Sales by Application (2012-2017)
7.4 United States Anthrax Vaccines Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Anthrax Vaccines Sales and Market Share by Manufacturer
7.4.2 United States Anthrax Vaccines Revenue and Market Share by Manufacturer
7.5 United States Anthrax Vaccines Export and Import (2012-2017)
8 Canada Anthrax Vaccines Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Anthrax Vaccines Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Anthrax Vaccines Sales and Market Share by Type
8.3 Canada Anthrax Vaccines Sales by Application (2012-2017)
8.4 Canada Anthrax Vaccines Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Anthrax Vaccines Sales and Market Share by Manufacturer
8.4.2 Canada Anthrax Vaccines Revenue and Market Share by Manufacturer
8.5 Canada Anthrax Vaccines Export and Import (2012-2017)
9 Mexico Anthrax Vaccines Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Anthrax Vaccines Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Anthrax Vaccines Sales and Market Share by Type
9.3 Mexico Anthrax Vaccines Sales by Application (2012-2017)
9.4 Mexico Anthrax Vaccines Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Anthrax Vaccines Sales and Market Share by Manufacturer
9.4.2 Mexico Anthrax Vaccines Revenue and Market Share by Manufacturer
9.5 Mexico Anthrax Vaccines Export and Import (2012-2017)
10 Anthrax Vaccines Market Forecast (2017-2022)
10.1 North America Anthrax Vaccines Sales, Revenue and Growth Rate (2017-2022)
10.2 Anthrax Vaccines Market Forecast by Countries (2017-2022)
10.2.1 United States Anthrax Vaccines Forecast (2017-2022)
10.2.2 Canada Anthrax Vaccines Forecast (2017-2022)
10.2.3 Mexico Anthrax Vaccines Forecast (2017-2022)
10.3 Anthrax Vaccines Market Forecast by Type (2017-2022)
10.4 Anthrax Vaccines Market Forecast by Application (2017-2022)
11 Anthrax Vaccines Manufacturing Cost Analysis
11.1 Anthrax Vaccines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Anthrax Vaccines
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Anthrax Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Anthrax Vaccines Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source


List of Tables and Figures

Figure Anthrax Vaccines Picture
Table Product Specifications of Anthrax Vaccines
Figure North America Sales Market Share of Anthrax Vaccines by Types in 2016
Table Types of Anthrax Vaccines
Figure Live Vaccines Picture
Table Major Manufacturers of Live Vaccines
Figure Cell free PA Vaccines Picture
Table Major Manufacturers of Cell free PA Vaccines
Table North America Anthrax Vaccines Sales Market Share by Applications in 2016
Table Applications of Anthrax Vaccines
Figure Human Use Picture
Figure Animal Use Picture
Figure United States Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Table Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table Emergent BioSolutions Anthrax Vaccines Type and Applications
Table Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merial Basic Information, Manufacturing Base and Competitors
Table Merial Anthrax Vaccines Type and Applications
Table Merial Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Anthrax Vaccines Type and Applications
Table Merck Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Zoetis Basic Information, Manufacturing Base and Competitors
Table Zoetis Anthrax Vaccines Type and Applications
Table Zoetis Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Sanidad Animal Basic Information, Manufacturing Base and Competitors
Table Bayer Sanidad Animal Anthrax Vaccines Type and Applications
Table Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Colorado Serum Basic Information, Manufacturing Base and Competitors
Table Colorado Serum Anthrax Vaccines Type and Applications
Table Colorado Serum Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PharmAthene Basic Information, Manufacturing Base and Competitors
Table PharmAthene Anthrax Vaccines Type and Applications
Table PharmAthene Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tiankang Basic Information, Manufacturing Base and Competitors
Table Tiankang Anthrax Vaccines Type and Applications
Table Tiankang Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biog

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

Report's License Type

$4480
$8960

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.